Form 4: Bio-Rad Laboratories Director Hany Massarany Increases Stake in Bio-Rad Laboratories

Director Hany Massarany recently purchased 22,500 shares of Bio-Rad Laboratories (BDSX) common stock at an average price of $1.3718 per share.

Summary

• On November 5, 2024, Hany Massarany, a director of Bio-Rad Laboratories (BDSX), acquired 22,500 shares of common stock.
• The shares were purchased at a weighted average price of $1.3718, with individual prices ranging from $1.355 to $1.39.
• Following the transaction, Mr. Massarany directly owns 283,767 shares and indirectly owns 53,364 shares through the Massarany Family Trust dated November 15, 2012.
• Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction by a company director. While insider purchases can be seen as positive, this is a relatively small transaction and doesn't necessarily indicate a strong bullish signal.

Positives

• The director's purchase could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This purchase increases the director's stake in the company.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates